$309 Million is the total value of Anson Funds Management LP's 96 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMZN | New | AMAZON COM INCput | $30,077,000 | – | 44,500 | +100.0% | 9.74% | – |
| AAPL | New | APPLE INCput | $26,526,000 | – | 252,000 | +100.0% | 8.59% | – |
| FB | New | FACEBOOK INCput | $13,606,000 | – | 130,000 | +100.0% | 4.41% | – |
| CSWC | New | CAPITAL SOUTHWEST CORPcall | $9,438,000 | – | 680,000 | +100.0% | 3.06% | – |
| NFLX | New | NETFLIX INCput | $8,007,000 | – | 70,000 | +100.0% | 2.59% | – |
| TRCO | New | TRIBUNE MEDIA COcall | $6,086,000 | – | 180,000 | +100.0% | 1.97% | – |
| DSKX | New | DS HEALTHCARE GROUP INC | $3,787,000 | – | 1,473,643 | +100.0% | 1.23% | – |
| AFMD | New | AFFIMED N V | $2,658,000 | – | 373,344 | +100.0% | 0.86% | – |
| ONTY | New | ONCOTHYREON INC | $1,836,000 | – | 827,203 | +100.0% | 0.60% | – |
| VPCOU | New | VAPOR CORP DELunit 99/99/9999 | $1,581,000 | – | 145,198 | +100.0% | 0.51% | – |
| CERE | New | CERES INC | $1,537,000 | – | 4,728,318 | +100.0% | 0.50% | – |
| TK | New | TEEKAY CORPORATION | $1,234,000 | – | 125,000 | +100.0% | 0.40% | – |
| ANY | New | SPHERE 3D CORP NEW | $1,069,000 | – | 705,668 | +100.0% | 0.35% | – |
| SSRI | New | SILVER STD RES INC | $1,007,000 | – | 194,447 | +100.0% | 0.33% | – |
| SKLNU | New | SKYLINE MED INCunit 99/99/9999 | $583,000 | – | 83,333 | +100.0% | 0.19% | – |
| SPEX | New | SPHERIX INC | $584,000 | – | 3,989,259 | +100.0% | 0.19% | – |
| PCO | New | PENDRELL CORP | $465,000 | – | 928,449 | +100.0% | 0.15% | – |
| ADAP | New | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $371,000 | – | 30,737 | +100.0% | 0.12% | – |
| LNCOQ | New | LINNCO LLC | $364,000 | – | 357,296 | +100.0% | 0.12% | – |
| APT | New | ALPHA PRO TECH LTD | $352,000 | – | 201,210 | +100.0% | 0.11% | – |
| SNTA | New | SYNTA PHARMACEUTICALS CORP | $348,000 | – | 989,204 | +100.0% | 0.11% | – |
| ALQA | New | ALLIQUA BIOMEDICAL INC | $344,000 | – | 160,925 | +100.0% | 0.11% | – |
| QLTI | New | QLT INC | $338,000 | – | 127,000 | +100.0% | 0.11% | – |
| ROSG | New | ROSETTA GENOMICS LTD | $338,000 | – | 274,545 | +100.0% | 0.11% | – |
| ECTM | New | ECA MARCELLUS TR I | $338,000 | – | 223,876 | +100.0% | 0.11% | – |
| LF | New | LEAPFROG ENTERPRISES INCcl a | $337,000 | – | 475,038 | +100.0% | 0.11% | – |
| EVAR | New | LOMBARD MED INC | $337,000 | – | 249,603 | +100.0% | 0.11% | – |
| VHC | New | VIRNETX HLDG CORP | $332,000 | – | 129,174 | +100.0% | 0.11% | – |
| FHCO | New | FEMALE HEALTH CO | $331,000 | – | 228,300 | +100.0% | 0.11% | – |
| RXII | New | RXI PHARMACEUTICALS CORP NEW | $328,000 | – | 858,068 | +100.0% | 0.11% | – |
| SPRT | New | SUPPORT COM INC | $321,000 | – | 318,200 | +100.0% | 0.10% | – |
| ATRS | New | ANTARES PHARMA INC | $321,000 | – | 265,425 | +100.0% | 0.10% | – |
| ROYTL | New | PACIFIC COAST OIL TRunit ben int | $315,000 | – | 238,873 | +100.0% | 0.10% | – |
| KIN | New | KINDRED BIOSCIENCES INC | $311,000 | – | 91,470 | +100.0% | 0.10% | – |
| TEAR | New | TEARLAB CORP | $311,000 | – | 223,700 | +100.0% | 0.10% | – |
| LLNW | New | LIMELIGHT NETWORKS INC | $310,000 | – | 212,239 | +100.0% | 0.10% | – |
| ROKA | New | ROKA BIOSCIENCE INC | $306,000 | – | 248,553 | +100.0% | 0.10% | – |
| MOSY | New | MOSYS INC | $302,000 | – | 277,342 | +100.0% | 0.10% | – |
| VSTM | New | VERASTEM INC | $302,000 | – | 162,286 | +100.0% | 0.10% | – |
| PXLW | New | PIXELWORKS INC | $270,000 | – | 113,400 | +100.0% | 0.09% | – |
| TTPH | New | TETRAPHASE PHARMACEUTICALS I | $256,000 | – | 25,500 | +100.0% | 0.08% | – |
| PRSNW | New | PERSEON CORP*w exp 99/99/999 | $251,000 | – | 1,047,703 | +100.0% | 0.08% | – |
| GNOW | New | AMERICAN CARESOURCE HLDGS IN | $240,000 | – | 584,945 | +100.0% | 0.08% | – |
| PLG | New | PLATINUM GROUP METALS LTD | $217,000 | – | 1,537,500 | +100.0% | 0.07% | – |
| WILN | New | WI-LAN INC | $211,000 | – | 158,000 | +100.0% | 0.07% | – |
| CPHRF | New | CIPHER PHARMACEUTICALS INC | $195,000 | – | 41,500 | +100.0% | 0.06% | – |
| ARDMQ | New | ARADIGM CORP | $193,000 | – | 48,542 | +100.0% | 0.06% | – |
| EVLV | New | EVINE LIVE INCcl a | $192,000 | – | 107,900 | +100.0% | 0.06% | – |
| RBCN | New | RUBICON TECHNOLOGY INC | $158,000 | – | 138,955 | +100.0% | 0.05% | – |
| CRDC | New | CARDICA INC | $122,000 | – | 791,350 | +100.0% | 0.04% | – |
| CNAT | New | CONATUS PHARMACEUTICALS INC | $119,000 | – | 41,300 | +100.0% | 0.04% | – |
| ATOS | New | ATOSSA GENETICS INC | $102,000 | – | 317,925 | +100.0% | 0.03% | – |
| KIQ | New | KELSO TECHNOLOGIES INC | $96,000 | – | 89,500 | +100.0% | 0.03% | – |
| WRN | New | WESTERN COPPER & GOLD CORP | $89,000 | – | 323,500 | +100.0% | 0.03% | – |
| NVGN | New | NOVOGEN LIMITEDcall | $85,000 | – | 40,800 | +100.0% | 0.03% | – |
| QBAK | New | QUALSTAR CORP | $80,000 | – | 104,083 | +100.0% | 0.03% | – |
| DNN | New | DENISON MINES CORP | $76,000 | – | 150,000 | +100.0% | 0.02% | – |
| PSTI | New | PLURISTEM THERAPEUTICS INC | $62,000 | – | 54,437 | +100.0% | 0.02% | – |
| AUMN | New | GOLDEN MINERALS CO | $48,000 | – | 241,193 | +100.0% | 0.02% | – |
| SNSS | New | SUNESIS PHARMACEUTICALS INC | $40,000 | – | 45,000 | +100.0% | 0.01% | – |
| BEBE | New | BEBE STORES INC | $39,000 | – | 68,496 | +100.0% | 0.01% | – |
| ENZN | New | ENZON PHARMACEUTICALS INC | $17,000 | – | 25,000 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 27 | Q3 2023 | 8.7% |
| BK OF AMERICA CORP | 24 | Q3 2023 | 15.9% |
| JPMORGAN CHASE & CO | 17 | Q2 2022 | 2.2% |
| MEDIGUS LTD | 17 | Q1 2023 | 0.0% |
| WISDOMTREE TR | 15 | Q2 2018 | 4.0% |
| RANDGOLD RES LTD | 15 | Q2 2018 | 3.3% |
| GRANITE REAL ESTATE INVT TR | 15 | Q3 2023 | 1.3% |
| BROOKFIELD ASSET MGMT INC | 15 | Q3 2022 | 1.3% |
| CENTRAL FD CDA LTD | 14 | Q1 2018 | 1.6% |
| MEI PHARMA INC | 14 | Q1 2023 | 1.2% |
View Anson Funds Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Appreciate Holdings, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Equity Distribution Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| GO Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| LogicMark, Inc. | February 14, 2023 | 987,399 | 9.9% |
| Model Performance Acquisition CorpSold out | February 14, 2023 | 0 | 0.0% |
| Mudrick Capital Acquisition Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| View, Inc. | February 14, 2023 | 24,597,185 | 9.9% |
| Amarantus Bioscience Holdings, Inc. | April 18, 2022 | 14,176,424 | 5.0% |
| Dune Acquisition Corp | February 11, 2022 | 100,000 | 0.6% |
| PROPTECH INVESTMENT CORP. II | February 11, 2022 | 1,184,276 | 5.2% |
View Anson Funds Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| SC 13D/A | 2024-04-05 |
| DFAN14A | 2024-04-04 |
| 4 | 2024-02-26 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View Anson Funds Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.